Leukocyte recruitment is a hallmark of inflammation and depends on the local production of chemotactic factors and on the regulation of the chemotactic receptors expressed by leukocytes 1, 2 .
Among chemotactic factors, chemokines represent the main family of signals able to induce leukocyte recruitment in vitro and in vivo. CXCR2 is the major chemokine receptor responsible for neutrophil recruitment. CXCR2 engagement induces the rapid Gα i -dependent activation of phospholipase C (PLC)-β, phosphatidylinositol 3-kinase γ (PI3Kγ), guanine exchange factors for rho-and ras-small GTPases, talin and kindlin-3, a signaling cascade promoting rapid β2-integrin clustering as well as conformational changes leading to increased affinity. This process allows the arrest and crawling of neutrophils on the surface of the endothelial cell monolayer and their extravasation [3] [4] [5] .
Atypical chemokine receptors (ACKRs) represent a small subset of proteins that express a high degree of homology with chemokine receptors. However, ACKRs lack structural determinants supporting Gα i signaling, making them unable to activate canonical G protein-dependent receptor signaling and cell migration 6 . At the moment, the ACKR family includes four proteins, namely ACKR1 (Duffy antigen receptor for chemokines-DARC), ACKR2 (D6 or CCBP2), ACKR3
(CXCR7 or RDC1) and ACKR4 (CCRL1 or CCXCKR and CCR11). In virtue of their ability to bind chemokines, ACKRs were shown to regulate inflammation acting as scavenger receptors, promoting chemokine transcytosis or regulating chemokine gradient formation [6] [7] [8] [9] .
CCRL2 is a seven transmembrane protein that shares some structural and functional aspects with ACKRs, such as the lack of conventional GPCR signaling and the inability to induce cell migration 6, 10, 11 . CCRL2 is expressed by barrier cells, such as endothelial and epithelial cells, and by a variety of leukocytes, including macrophages, dendritic cells and neutrophils 6, 10 . CCRL2 was shown to bind and present chemerin, a non-chemokine chemotactic protein, to leukocytes expressing ChemR23, the functional chemerin receptor, a function that may be relevant for leukocyte extravasation 12, 13 . CCRL2 expression is upregulated by inflammatory signals but its function remains unclear. This study was performed to investigate the role of CCRL2 in neutrophils, a leukocyte subset known to play a crucial role in the innate defense against pathogens and also involved in pathological conditions, such as cancer and autoimmune disorders (e.g. rheumatoid arthritis) 2, 14, 15 . Here we report the ability of CCRL2 to regulate neutrophil migration and 
Flow cytometry analysis
Bone marrow (BM) cells were CD16/32 (2.4G2) blocked and stained with the following moAbs:
CD11b (M1/70), Ly6G (1A8), and F4/80 (BM8) from BD Pharmingen; anti-mouse CCRL2 (11n20) from LSBio; anti-mouse CXCR2-AlexaFluor647 (SA045E1) from Biolegend. Anti-ERK1/2 (T202/Y204) moAb from BD Pharmigen. Anti-active Rac1-GTP and anti-RhoA-GTP from NewEast Biosciences. Cells were acquired with MACSQuant (Miltenyi), or LSR Fortessa flow cytometer (BD Biosciences) and analysed by FlowJo software.
BM neutrophils isolation
BM neutrophils were isolated by negative selection using the neutrophil isolation kit (Miltenyi).
The purity of the neutrophil population was routinely more than 90% CD11b + Ly6G + cells.
Chemotaxis
Cell migration was evaluated using a 48-well chemotaxis chamber (Neuroprobe) and polycarbonate filters (5μ pore size; Neuroprobe) for 50-minute incubation as described 17 . Results are expressed as number of migrated cells in an average of 5 high-power fields (100x).
Ca 2+ mobilization
Purified neutrophils (3.75x10 6 
In vivo leukocytes mobilization
The recruitment of leukocytes into the peritoneal cavity after i.p. administration of human CXCL8 (300 ng) or LPS (15 ng) 18 at the indicated time points was analyzed in control and CCRL2-deficient mice by flow cytometry. Human CXCL8 is known to activate murine CXCR2 19 although with a lower affinity than other CXCR2 mouse ligands 20 .
Experimental Arthritis
Collagen-Induced Arthritis (CIA) was induced in 8-to 12-week-old male CCRL2-deficient and control mice as previously described 21 . CIA was induced in DBA1 mice with 100 μ g denatured type II bovine collagen (MD Biosciences) emulsified in CFA. For the induction of Serum-Transfer Induced Arthritis (STIA), mice were i.p. administered with 150 μ l serum from K/BxN transgenic mice (kindly provided by D. Mathis and C. Benoist) 22 . Paws were scored for disease severity as described 21 . At the end of the experiment, the joints were removed, fixed, decalcified, and paraffin embedded. Sections (4 μ m) were stained with H&E and Ly6G. Antigen-induced arthritis was induced by intradermally immunization with metBSA as previously described 23 . Anti-collagen antibodies in mouse sera were measured by Arthrogen-CIA ELISA kit (Chondrex) 21 .
BM transplantation
Control or CCRL2-deficient mice were lethally irradiated with a total dose of 9 Gy. Then, 2 hrs later, mice were injected in the tail vein with 5×10 6 nucleated control or CCRL2-deficient BM cells.
At 8 weeks after bone marrow transplantation, the STIA model was performed.
Real-time PCR
Total RNA was extracted with RNeasy kit (Quiagen). Real-time quantitative PCR reactions were performed on a MJ Real Time PCR system (Biorad), using a SYBR Green PCR master mix (Applied Biosystems) 16 .
Under-flow adhesion assay
Neutrophil behavior in underflow conditions was studied with the BioFlux 200 system (Fluxion Biosciences). 48-well plate microfluidics were first co-coated overnight at RT with 2.5 μg/ml murine E-selectin and 5 μg/ml murine ICAM-1 in PBS. Before use, microfluidic channels were washed with PBS and then coated with 4 μ M CXCL8 for 3 hrs at RT and the assay was done at shear stress of 2 dyne/cm 2 24 .
Intravital Microscopy
Intravital microscopy was performed in the synovial microcirculation of mouse knee, as described 23 . Briefly, the left hind limb was placed on a stage, the patellar tendon mobilized and partly resected, and the intraarticular knee synovial tissue visualized. To measure the leukocyteendothelial cell interactions, the fluorescent marker rhodamine 6G (Sigma) was i.v. injected (0.15 mg/kg) before the measurements. Images were captured with an Axiocam 503 Mono digital camera (Zeiss).
Elastase release
BM neutrophils (10 7 cells/ml) preincubated with cytochalasin B were treated with CXCL8 or CXCL1. Elastase release was determined as elastase activity measured in conditioned cell media and fluorescence was monitored (370/460nm, EnSight™ Multimode Plate Reader, PerkinElmer).
Time-lapse microscopy assay
BM purified neutrophils were o/n LPS stimulated, then seeded on matrigel pre-coated glass plate.
Micropipette (FemtotipII, Eppendorf) was loaded with 10μl of CXCL8 (100μg/ml) and injected at 15hPa pressure. Acquisition was performed with Axio Cam MRm (Zeiss Microscopy).
FRET experiments
For homodimer studies HEK293T cells were cotransfected with a constant amount of CXCR2-CFP (1.5μg/well, 3x10 5 cells) and increasing amounts of CXCR2-YFP (0.125-4.5μg/well) 25 
Results

Neutrophil recruitment is defective in CCRL2-deficient mice
Freshly isolated mouse neutrophils were found to express basal levels of membrane CCRL2.
Culturing neutrophil in the absence of stimulation induced CCRL2 downregulation (105±11 and 57±10, MFI±SEM of fresh vs. 18 hrs cultured neutrophils). On the contrary, overnight stimulation with LPS or with the combination of pro-inflammatory agonists (i.e. LPS, TNFα and IFNγ), caused a strong increase in CCRL2 expression with the majority of the cells co-expressing CCRL2 and CXCR2 ( Fig. 1A ). Chemotactic agonists, namely fMLP, C5a and CXCL8 did not regulate CCRL2 expression (data not shown). To investigate the biological role of CCRL2, neutrophil recruitment was evaluated in vivo two hrs after the intraperitoneal injection of LPS. A marked reduction in neutrophil count was observed in CCRL2-deficient mice, compared to WT animals ( 1C ) and after the administration of methylated bovine serum albumin into the knee joint of previously immunized CCRL2-deficient mice (Fig. 1D ). These results were not due to reduced bone marrow mobilization, since similar numbers of CD11b + /Ly6G + cells were detected in the bone marrow and in circulation of WT and CCRL2-deficient mice after CXCL8 administration ( Supplementary Fig. 2 ).
CCRL2-deficient mice are protected in experimental models of inflammatory arthritis
Different mouse models of experimental arthritis have highlighted the crucial role of neutrophils in the development of inflammatory joint diseases. Neutrophil recruitment to the inflamed joint is accomplished through the sequential activation of multiple chemokine receptors, which involves first the receptor for the lipid inflammatory mediator leukotriene B4 (LTB4) and then the chemokine receptors CXCR1/CXCR2 and CCR1 23, 27, 28 .
CCRL2-deficient mice were tested first in the model of collagen-induced arthritis to study the priming phase, consisting in the activation of the specific immune response to collagen type II, as well as the inflammatory effector phase of the disease, characterized by local inflammation, cartilage and joint destruction 29 . Figure 2A shows that CCRL2-deficient mice were protected and developed arthritis with a lower incidence compared to WT controls (16.67% vs. 34.48%
respectively; data not shown). CCRL2-deficient mice showed also a statistical significant delay in the onset of the disease (day +25 vs. day +20, in CCRL2 KO vs. WT mice, respectively) and a marked decrease in its severity. Consistent with these results, histopathological examination highlighted a marked reduction in synovial inflammation, pannus formation and erosion of the articular cartilage ( Fig. 2B and C). The reduced severity of disease observed in CCRL2-deficient mice was not associated with changes in anti-collagen type II antibody serum levels ( Fig. 2D ),
suggesting that CCRL2-associated protection is mostly confined to the inflammatory effector phase rather than on the induction phase of the disease. Of interest, the repeated administration of an anti-CCRL2 moAb to DBA1 mice, a strain more susceptible to CIA (100% incidence at day 36) than C57BL/6 mice 30 , produced a degree of protection comparable to that observed in CCRL2-deficient animals (Fig. 3A) .
The effector phase of arthritis was further investigated using the experimental model of the
STIA is a more rapid and aggressive model than CIA that it was found to be suitable for the preclinical study of new therapeutic strategies 32 . Fig. 3B depicts that also in this model, the appearance of the clinical symptoms was delayed in CCRL2deficient mice with a maximal clinical score at the peak of disease (day +4) that was only 43 % of that observed in WT animals. Also in the STIA model, the administration of an anti-CCRL2 moAb induced in WT animals a degree of protection that was similar to that observed in CCRL2-deficient mice. Immunohistochemical analysis of Ly6G + cells revealed that neutrophil infiltration was strongly reduced in CCRL2 KO and in WT mice treated with an anti-CCRL2 moAb, compared to WT mice ( Fig 3C) . At day +4, the circulating levels of IL-6, a systemic marker of inflammation, were significantly reduced in CCRL2-deficient mice, as well as the levels of the neutrophil chemotactic cytokines CXCL1 and CXCL2 and the T cell attracting chemokine CCL5. As expected based on previous work 33 , in CCRL2 KO mice, serum levels of chemerin were increased by 26.7% ( Fig. 3D ).
Bone marrow chimera obtained by WT and CCRL2-deficient bone marrow transfer
identified hematopoietic cells as the major component conferring protection in KO mice in STIA.
Indeed, transplantation of CCRL2-deficient bone marrow cells in WT mice recapitulated the protective phenotype observed in KO mice transplanted with CCRL2-deficient bone marrow cells, while transplantation of WT bone marrow cells in KO mice abolished the protective phenotype ( Supplementary Fig. 3 ). Finally, adoptive transfer of WT, but not CCRL2-deficient neutrophils abolished the protection of CCRL2-deficient mice, identifying these cells as the main CCRL2expressing population responsible for the protective phenotype observed in CCRL2-deficient mice
CCRL2-deficient neutrophils are defective in CXCR2-mediated signaling
To investigate the mechanisms responsible for the defective in vivo neutrophil migration, a more detailed analysis was performed by intravital microscopy using the model of metBSA-induced arthritis. As shown in Figure 4A , 24 hrs after the administration of the antigen into the knee of immunized WT mice, numerous cells were found adherent to the vessels located in the knee that received the antigen (left knee). No adherent cells were observed in the control joint (right knee) that received only saline (see also Supplementary Movie 1 and 2). On the contrary, the inflamed joints (left knee) of CCRL2-deficient animals showed a strong reduction of endothelial celladherent leukocytes, with the majority of the cells undergoing the rolling process on the endothelial layer ( Figure 4A and Supplementary Movie 3 and 4). These results strongly suggested that CCRL2deficient neutrophils may have a defect in integrin mediated arrest.
To address this hypothesis, the ability of bone marrow-purified neutrophils to undergo rolling and adhesion was investigated in vitro under flow conditions. At the shear stress of 2 dyne/cm 2 , which resembles the physiological shear stress normally acting in postcapillary venules, CCRL2-deficient neutrophils showed a defective ability to undergo rapid (1 sec) arrest on Eselectin-, ICAM-1-and CXCL8-coated glass capillaries. As expected, a higher number of rolling cells was counted using CCRL2 KO neutrophils compared to WT cells (Fig. 4B ). This defect was best observed at the very early time points of arrest, becoming much less dramatic when the arrest parameter was set at 10 secs, a time point more likely consistent with phenomena of post-binding stabilization and, possibly, outside-in signaling. Consistent with in vivo findings ( Fig. 3) , treatment with an anti-CCRL2 moAb recapitulated the defective arrest observed with CCRL2-deficient neutrophils (Fig. 4B ). These findings clearly support the concurrent regulatory cooperation of CCRL2 and CXCR2 in triggering β2-integrin activation and mediated rapid arrest.
To better understand the molecular basis for the defective cell adhesion, the CXCR2mediated signaling was investigated. Stimulation of freshly isolated CCRL2-deficient neutrophils with CXCL8 produced lower levels of phospho-ERK along the entire kinetics investigated, when compared to WT cells (Fig. 4C ). This defect was specific for CXCL8, since normal ERK1/2 phosphorylation was observed in CCRL2-deficient cells stimulated with CCL3, LTB4 or PMA ( Supplementary Fig. 4 ). Similarly, CXCL8-stimulated CCRL2-deficient neutrophils showed defective phosphorylation of RhoA and Rac1 small GTPases, two key elements in chemotactic receptor signaling ( Fig. 4D CCRL2 KO neutrophils also displayed reduced release of elastase in response to CXCL8 or CXCL1, but not in response to fMLP ( Fig. 5A and data not shown). On the contrary, neutrophil chemotaxis, investigated in vitro using the modified Boyden chamber assay, showed a normal migration of CCRL2-deficient cells in response to a panel of chemotactic agonists, including lipids (i.e. LTB4 and platelet activating factor) and chemokines (i.e. CXCL1, CXCL8 and CCL3). No migration of WT or CCRL2-deficient neutrophils was observed in response to the chemotactic protein chemerin, confirming the lack of expression of ChemR23 by both resting and activated neutrophils ( Fig. 5B and data not shown) 34 . Using time-lapse microscopy migration assays, CCRL2-deficient neutrophils showed a normal ability to orient and migrate to a CXCL8 gradient on a matrigel-coated surface (Fig. 5C , left panel) 35 . However, following LPS activation, which upregulates CCRL2 expression ( Fig. 1 ), CCRL2-deficient neutrophils revealed a reduced velocity in response to a CXCL8 gradient, compared to WT cells, suggesting that the upregulation of CCRL2 is associated with a positive regulation of the chemotactic response to CXCL8 possibly related to a better interaction of WT cells with extracellular matrix components ( Fig. 5E , right panel).
CCRL2 and CXCR2 form both homodimers and heterodimers
Heterodimers between receptors have been proposed as a mechanism that modulates chemokine functions [36] [37] [38] [39] . To investigate the molecular basis of CCRL2 regulation of CXCR2 signaling and function we evaluated the possibility that these two receptors, when co-expressed, may form heterodimers. We generated FRET saturation curves using HEK293T cells transiently cotransfected with constant amounts of donor (CXCR2-or CCRL2-CFP) and increasing amounts of acceptor (CXCR2-or CCRL2-YFP). Positive FRET was observed for CXCR2 and CCRL2 homodimers ( Fig. 6A and B ) and for CCRL2/CXCR2 heterodimers ( Fig. 6C ). As a negative control, we used the Histamine 3 receptor (H3R), indicating the specificity of the interaction between CCRL2 and CXCR2 ( Fig. 6A and B ).
To corroborate these data and to determine the intracellular localization of the heterodimeric complexes, we transiently cotransfected HEK293T cells with CCRL2-CFP (donor) and CXCR2-YFP (acceptor) at a YFP/CFP ratio at which the FRET 50 signal was detected in saturation curves ( Fig. 6C ), and determined FRET by the acceptor photobleaching method. To verify that transfection ratios corresponded to the equivalent YFP/CFP ratio determined, we measured YFP and CFP fluorescence separately in each image. CCRL2 and CXCR2 heterodimers were detected both at the cell membrane and in the cytoplasm (Fig. 6D) , confirming heterodimerization between the two receptors and suggesting the existence of a pool of receptors retained intracellularly. Of note, FRET efficiency was higher for the intracellular complexes indicating differences in the conformation of the heterodimer depending on the cell localization evaluated. The intracellular retention of CCRL2/CXCR2 complexes was confirmed by FACS using an anti-CXCR2 specific moAb. The levels of CXCR2 at the cell membrane were reduced by 25.8% when HEK293T cells were cotransfected with CCRL2 (Fig. 6E ). In agreement with these data, freshly isolated neutrophils obtained from CCRL2-deficient mice were characterized by a corresponding increase of membrane MFI when stained with an anti-CXCR2 moAb, suggesting the KO cells express higher levels of membrane CXCR2 than WT neutrophils (Fig. 6F ).
CCRL2 expression modulates CXCR2 homodimeric complexes
FRET was also used to determine whether CCRL2 expression influences CXCR2 
Discussion
Inflammation is characterized by the regulated recruitment of leukocytes at the site of injury, with neutrophils usually being the first recruited cell population 15, 40 . The results presented here
show that the expression of CCRL2 is critical for full CXCR2 signaling and β2-integrin activation in stimulated neutrophils.
The relevance of CCRL2 upregulation under inflammatory conditions is well documented by the use of CCRL2-deficient mice in two models of inflammatory arthritis. These models directly rely on neutrophil recruitment 23, 27, 28, 41 . CCRL2-deficient mice were strongly protected in terms of onset, tissue damage and severity of the disease, with respect to WT animals. Of note, the administration of an anti-CCRL2 moAb to WT mice induced a degree of protection comparable to that observed in CCRL2-deficient animals. The two experimental models of arthritis used involve the action of multiple effector cells, including macrophages and mast cells 32 . By adoptive transfer experiments performed in the STIA model we have excluded a role of CCRL2 expression in mast cells (data not shown), although we cannot exclude the involvement of other CCRL2 + effector cells.
However, since the adoptive transfer of WT neutrophils reversed the protective phenotype of CCRL2 KO mice, neutrophils are likely to be the main cell subset regulated by CCRL2 expression in STIA. CCRL2 mRNA was reported to be expressed by neutrophils purified from the synovial fluid of rheumatoid arthritis patients 42 . Although human neutrophils differ from the murine counterpart in many aspects, including membrane markers, cytokine production and functions 43, 44 , these results candidate CCRL2 as a novel potential target in rheumatoid arthritis possibly to be exploited as a complementary therapy in low-responder patients 45, 46 .
CXCR2-mediated signaling was impaired in CCRL2-deficient neutrophils and this defect is likely to be responsible for the reduced activation of β2-integrins. In this context it is interesting to note that β2-integrin expression on neutrophils was reported to be crucial for arthritis development in STIA 47 . In the attempt to clarify the molecular mechanisms responsible for this effect, it was observed that CCRL2 and CXCR2 form homo and heterodimers. CCRL2/CXCR2
heterodimerization was found to regulate CXCR2 membrane expression and signaling, and to modulate the formation of CXCR2 homodimeric complexes.
GCPRs, including chemokine receptors, are known to form homo and heterodimers and this process is known to regulate their functions, including intracellular trafficking and signaling pathways [36] [37] [38] [39] 48 . Two members of the ACKR family were previously reported to form both homo and heterodimers. ACKR1 can constitutively form heterodimers with CCR5, a receptor with which it shares the ligand, namely CCL5 6 the inhibition of CCR5 signaling and activity 49 . Similarly, ACKR3 forms constitutive heterodimers with CXCR4, a receptor with which it shares the ligand, CXCL12. The formation of ACKR3/CXCR4 heterodimers was reported to be crucial for CXCL12-induced intracellular signaling (e.g. calcium flux and ERK1/2 phosphorylation) 37, 38 . Thus, ACKR1 and ACKR3 can form oligomers with receptors with which they share the same ligand. In this scenario, CCRL2 is apparently unique among the atypical chemotactic receptors, since it forms heterodimers and regulates the function of CXCR2, the receptor for CXCL8, a chemokine that does not bind CCRL2.
Chemokines have fundamental roles in regulating immune and inflammatory responses and during evolution several strategies developed to control their biological activity 6, 8, 50 , ACKRs being one of such strategies. In contrast to classic chemokine receptors, ACKRs are generally expressed by non-leukocyte cell types, such as barrier cells (i.e. epithelial and endothelial cells) and do not activate G protein-dependent signaling 6, 8, 9, 51 . Rather, upon binding of their ligands, ACKRs transport chemokines to intracellular degradative compartments or in certain cell types, to the opposite side of the cell monolayer by a β-arrestin-dependent pathway 52,53 . These scavenging properties make ACKRs important molecules in the regulation of the inflammatory response 1, 9 . At difference from the other ACKRs, CCRL2 is expressed by leukocytes, including macrophages, dendritic cells, mast cells, microglia and neutrophils. In addition, CCRL2 does not apparently internalize in a constitutive manner or activate β-arrestin-dependent pathways 10-12 . Nevertheless, CCRL2 was reported to regulate the immune response in a model of IgE-mediated cutaneous anaphylaxis and in a model of lung hypersensitivity 12, 16 . In this regard it is interesting to note that in CCRL2-deficient mice, lung dendritic cells were reported to be defective in their migration to mediastinal lymph nodes 16 , a process known to be dependent on CCR7 and CCR8 54 . Therefore, it is tempting to speculate that CCRL2 might also regulate the function of other chemokine receptors.
In conclusions, these results identify a novel pathway of regulation of neutrophil recruitment dependent on the expression of the atypical receptor CCRL2. Although in vivo we cannot formally exclude the involvement of other receptors, our data strongly suggest that CXCR2 is a main target of CCRL2 regulation. The spectrum and structural components of CCRL2 tuning functions still remain to be fully elucidated. Nevertheless, the results obtained using gene modified mice and the anti-CCRL2 moAb candidate this receptor as a potential target for inhibiting neutrophil sustained 
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The authors declare no competing financial interests. digital drive with fast CCD video camera (25 frames/s, capable of 1/2 subframe 20 msec recording) and analyzed subframe by subframe. Single areas of 0.2 mm 2 were recorded for at least 60 sec.
Interactions of 40 ms or longer were considered significant and scored 24 . Cells that remained firmly adherent for at least 1 sec were considered fully arrested. Cells arrested for at least 1 sec and then detached, or for 10 s and then remained adherent, were scored separately and plotted as independent 
